Nancy Guo

Nancy Guo is a SUNY Empire Innovation Professor at Binghamton University. Dr. Guo is a Fulbright US Scholar for Brazil on biomarker discovery. She is experienced in leading foundation AI-based multidisciplinary research as the PI of two NIH R01s and two NSF grants. She has secured over $46 million in federal funding as Principal Investigator/Project Director to develop technology and infrastructure for advancing precision medicine. She has published 62 peer-reviewed journal articles with more than 4,408 citations. Her research has resulted in 14 patents on cancer drugs and molecular diagnostic assays with FDA “Novel Technology” status (currently under review).